v3.26.1
STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
SCHEDULE OF OPTIONS ACTIVITY

Transactions involving our options are summarized as follows:

 

           Weighted 
           Average 
       Weighted   Grant-Date 
   Number of   Average   Per Share 
   Options   Exercise Price   Fair Value 
Options outstanding at December 31, 2025   350,616,665   $0.05   $0.03 
Granted   25,000,000   $0.05   $0.03 
Canceled/Expired   (200,000)  $0.05   $0.02 
Exercised   -   $-   $- 
Options outstanding at March 31, 2026   375,416,665   $0.05   $0.03 
SCHEDULE OF OPTIONS OUTSTANDING

Details of our options outstanding as of March 31, 2026, are as follows:

 

Options Exercisable  

Weighted Average

Exercise Price of Options

Exercisable

  

Weighted Average

Contractual Life of Options

Exercisable (Years)

  

Weighted Average

Contractual Life of Options

Outstanding (Years)

 
 287,166,665    0.05    3.27    3.60 
SCHEDULE OF WARRANTS ISSUED

Transactions involving our warrants are summarized as follows:

 

       Weighted 
   Number of   Average 
   Shares   Exercise Price 
Warrants outstanding at December 31, 2025   914,640   $0.10 
Granted   -   $- 
Canceled/Expired   (468,795)  $0.10 
Exercised   -   $- 
Warrants outstanding at March 31, 2026   445,845   $0.10 
SCHEDULE OF WARRANTS OUTSTANDING

Details of our warrants outstanding as of March 31, 2026, are as follows:

 

Warrants Exercisable     Weighted Average
Contractual Life of Warrants
Outstanding and Exercisable (Years)
 
445,845     0.16